Title: Ernst Wülfert: Innovator in Neuroprotective Applications
Introduction: Ernst Wülfert is an inventor based in Brussels, Belgium. He is currently associated with Hunter-Fleming Limited. Although he does not hold any granted patents, his work focuses on significant advancements in neuroprotective applications and metabolic pathways.
Latest Patent Applications: Ernst Wülfert has submitted several notable patent applications. One of his latest applications is for "7-HYDROXYEPIANDROSTERONE HAVING NEUROPROTECTIVE ACTIVITY." This application discusses the use of 3-Hydroxy-7β-hydroxy steroids and 3-oxo-7β-hydroxy steroids, along with their pharmaceutically acceptable esters, for protection against neuronal damage. Another application is titled "MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE METABOLIC PATHWAYS." This application addresses various diseases and disorders associated with metabolic pathways involved in cyclooxygenase activities and prostaglandin synthesis. It suggests that agents which selectively enhance the production of 15-deoxy-prostaglandin J2 may treat or prevent conditions such as type 2 diabetes, ischemic vascular diseases, and various types of cancer.
Conclusion: Ernst Wülfert is a dedicated inventor whose work in neuroprotective applications and metabolic pathways holds promise for future medical advancements. His contributions, although not yet reflected in granted patents, demonstrate his commitment to innovation in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.